Persistent SARS-CoV-2 infection in patients with B-cell deficiency: a case series of successful antiviral treatment of four patients
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised patients remains a major medical challenge. Diagnosing the syndrome is difficult as symptoms may mimic other diseases and treatment guidelines are lacking. We describe a case series of four patient...
Main Authors: | Lisa Faxén, Marie Edvinsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Upsala Medical Society
2023-10-01
|
Series: | Upsala Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ujms.net/index.php/ujms/article/view/9807/16287 |
Similar Items
-
Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells
by: Maximilian Webendörfer, et al.
Published: (2021-02-01) -
Rituximab Therapy for Primary Sjögren’s Syndrome
by: Yi Han Chen, et al.
Published: (2021-09-01) -
Pemphigus Foliaceus—Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report
by: Magdalena Kraft, et al.
Published: (2018-11-01) -
COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge
by: Anna Furlan, et al.
Published: (2021-11-01) -
A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis
by: Lei Zhu, et al.
Published: (2021-05-01)